Impact of pre-transplant co-morbidities on outcome after alemtuzumab-based reduced intensity conditioning allo-SCT in elderly patients: A British Society of Blood and Marrow Transplantation study

Emmanouil Nikolousis,Sandeep Nagra,R Pearce,J Perry,Keiren Kirkland,Jennifer L. Byrne,Fiona L. Dignan,Eleni Tholouli,M Gilleece,Nigel H. Russell,Timothy Littlewood,Mark E. Cook,Andrew Peniket,Bronwen E. Shaw,Graham P. Cook,Charles G. Craddock

Impact of pre-transplant co-morbidities on outcome after alemtuzumab-based reduced intensity conditioning allo-SCT in elderly patients: A British Society of Blood and Marrow Transplantation study

2015

Emmanouil Nikolousis
Sandeep Nagra
R Pearce
J Perry
Keiren Kirkland
Jennifer L. Byrne
Fiona L. Dignan
Eleni Tholouli
M Gilleece
Nigel H. Russell
Timothy Littlewood
Mark E. Cook
Andrew Peniket
Bronwen E. Shaw
Graham P. Cook
Charles G. Craddock

Impact of pre-transplant co-morbidities on outcome after alemtuzumab-based reduced intensity conditioning allo-SCT in elderly patients: A British Society of Blood and Marrow Transplantation study

Keywords:

Progenitor cell
Graft-versus-host disease
Diabetes mellitus
Stem cell
Immunology
Reduced Intensity Conditioning
Alemtuzumab
Transplantation
Medicine
Survival rate
Transplantation Conditioning
Retrospective cohort study
Regimen
Hematopoietic stem cell transplantation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations